Abstract. Affinity-labeling experiments have detected hetero-oligomers of the types I, II, and UI transforming growth factor/3 (TGF-/3) receptors which mediate intracellular signaling by TGF-/3, but the oligomeric state of the individual receptor types remains unknown. Here we use two types of experiments to show that a major portion of the receptor types II and HI forms homo-oligomers both in the absence and presence of TGF-/3. Both experiments used COS-7 cells co-transfected with combinations of these receptors carrying different epitope tags at their extracellular termini. In immunoprecipitation experiments, radiolabeled TGF-13 was bound and cross-linked to cells coexpressing two differently tagged type II receptors. Sequential immunoprecipitations using anti-epitope monoclonal antibodies showed that type II TGF-/3 receptors form homo-oligomers. In cells co-expressing epitope-tagged types II and III receptors, a low level of co-precipitation of the ligand-labeled receptors was observed, indicating that some hetero-oligomers of the types II and III receptors exist in the presence of ligand.
1. Abbreviations used in this paper: HA, influenza hemagglutinin; TGF-/3, transforming growth factor j3; TGF-/3RI, TGF-/3RII, and TGF-/3RIII, TGF-/3 receptor types I, II and II/, respectively; DSS, disuccinimidyl suberate; ct-myc, mouse monoclonal antibody which recognizes a specific c-myc sequence; c~-HA, mouse monoclonal antibody which recognizes an epitope of the influenza hemagglutinin (HA) protein; FITC-IgG GctRIgG, fluorescein-coupled goat IgG anti-rabbit IgG; G~tMIgG, goat IgG anti-mouse IgG; Cy3-Fab' G~tMIgG, goat Fab' anti-mouse IgG conjugated to the cyanine dye Cy3.18. al., 1990; Lin and Lodish, 1993) . Chemical cross-linking to nSI-TGF-13 reveals numerous proteins that bind the ligand with high affinity, including cell-surface receptors as well as soluble and extracellular matrix proteins (Massagu6, 1992; Lin and Lodish, 1993) . Among the cell-surface receptors, the most widely distributed are the types I (55 kD), II (80 kD), and HI (280 kD) TGF-/3 receptors (Cheifetz et al., 1987; Segarini et al., 1989; Massagu6, 1992; Lin and Lodish, 1993) . The TGF-B receptors type I (TGF-/3RI) and type II (TGF-/3RID are thought to mediate the multiple effects of TGF-/3, while type I~ receptors (TGF-BRIII) are involved in presentation of the ligand to the signaling receptors (reviewed in Massagu6, 1992; Lin and Lodish, 1993) .
TGF-/3RIII is a transmembrane proteoglycan with a short, highly conserved, cytoplasmic domain that has no apparent signaling motif (Wang et al., 1991; L6pez-Casillas et al., 1991; Mor6n et al., 1992) . In most cell types TGF-/3RIII is the most abundant TGF-/3 receptor subtype (Segarini et al., 1989; Massagu6, 1992) . TGF-/3RIII and its soluble secreted ectodomain (Andres et al., 1989 ) may act as "reservoir" molecules for ligand presentation to or retention from the sig-naling TGF-/3RII and TGF-/3RI receptors (Andres et al., 1989; Massagu6, 1992; Lin and Lodish, 1993) . Expression of TGF-/3RIII enhances binding of TGF-/3 ligands, particularly TGF-/32, to TGF-/3RII and thus some regulatory interactions exist between the types II and HI TGF-/3 receptors (L6pez-Casillas et al., 1993; Moustakas et al., 1993) . Immunoprecipitation experiments provided evidence for cellsurface complexes containing both types II and HI TGF-fl receptors. That the TGF-/3RIII primarily has a modulatory role is in accord with its structural features and is also consistent with the observation that TGF-/3RIII is absent in several ceils that are responsive to TGF-/3 (Ohta et al., 1987; Segarini et al., 1989) .
TGF-/3RII is a transmembrane serine/threonine kinase (Lin et al., 1992; Wrana et al., 1992; Tsuchida et al., 1993a) . It belongs to the family of receptor serine/threonine kinases that includes the mammalian, Xenopus and Drosophila activin type II receptors (Mathews and Vale, 1991; Legerski et al., 1992; Mathews and Vale, 1992; Nishimatsu et al., 1992; Shinozaki et al., 1992; Childs et al., 1993 ) and the daf-1 and daf-4 gene products of Caenorhabditis elegans. The latter two receptors control development of the dauer larva (Georgi et al., 1990) ; the daf-4 gene product can act as a type II receptor for bone morphogenetic protein (BMP) (Estevez et al., 1993) . Recently, specific eDNA clones were identified as encoding type I TGF43 receptors Bassing et al., 1993; Ebner et al., 1993a,b; Franz~n et al., 1993) and the closely related type I activin receptors Ebner et al., 1993b; Matsuzaki et al., 1993; Tsuchida et al., 1993b) . These integral membrane proteins are shorter than the TGF-#RII or activin type II receptors, but possess a serine/threonine kinase domain and share conserved sequences with the type II receptors in both their extra-and intracellular domains. Thus, types II and I receptors belong to homologous branches of the receptor serine/threonine kinase family. Several members of this family with presently unidentified ligand specificity have recently been reported (He et al., 1993; ten Dijke et al., 1993) .
Studies using chemically mutated mink lung epithelial cells (Boyd and Massagu6, 1989; Laiho et al., 1990 Laiho et al., , 1991 and tumor cell lines (Kirnchi et al., 1988; Segarini et al., 1989; Siepl et al., 1991; Geiser et al., 1992) that have lost the growth-inhibitory response to TGF-/3 and concomitantly lost cell-surface receptors TGF-13RI, TGF-#RII, or both, have led to the notion that both TGF-/3RI and TGF-/3RII are required for TGF-/3-mediated signaling. Functional interactions between TGF-/3RII and TGF-/3RI are suggested by studies showing that TGF-/3RII requires TGF-/3RI for signaling, while binding of TGF-/31 to TGF-BRI can be detected only when this receptor is co-expressed with TGF-~RII Attisano et al., 1993; Bassing et al., 1993; Ebner et al., 1993a, b; Franz6n et al., 1993; Inagaki et al., 1993; Wieser et al., 1993) . Moreover, some heteromeric complexes of the types II and I receptors exist, since some "I'GF-/3RI, affinity labded with 125I-TGF-/31, can be co-imrnunoprecipitated with TGF-/~RII.
The important implications of functional interactions among cell-surface TGF-/3 receptors emphasize the need for a thorough investigation of their oligomeric structure, which is still largely unknown. In the current work, we investigated the formation of homo-and hetero-oligomers among TGF-/3RtI and TGF-/3RHI at the cell surface under native conditions. Using cells that were co-transfected with various combinations of epitope tagged and/or wild-type TGF-/3RII and TGF-/3RIII, we performed double-labeling immunofluorescence experiments based on the forced patching of one TGF-/3 receptor and following the distribution of the other co-expressed receptor. Complemented with immunoprecipitation studies, our data show that both the TGF-/3RII and TGF-/3RIII are present at the cell surface as homo-oligomers (possibly dimers in the case of the type II receptors) even prior to the addition of ligand. Furthermore, we show that heteromeric TGF-/3RII/TGF-/3RHI complexes which form following ligand binding involve only a minor fraction of the cell-surface receptor population.
Materials and Methods

Materials
TGF-B1 and -/32 were supplied by Celtrix Laboratories (Palo Alto, CA) and R & D Systems (Minneapolis, MN), and were radioiodinated as described (Wang et al., 1991; Mitchel et al., 1992) . 9El0 (a-myc) mouse ascites, which recognizes a specific c-myc sequence (Evan et ai., 1985) , was purchased from Harvard Monoclonals (Boston, MA). 12CA5 (a-HA) mouse ascites, which recognizes an epitope of the influenza hemagglutinin (HA) protein (Wilson et al., 1984) , was purchased from BAbCO (Berkeley, CA). ~-IIN antibodies, raised in rabbits against a KLH-coupled peptide corresponding to the Lys3°-Ala 44 segment of the human TGF-BRH, were those described by us earlier and shown to be specific for the TGF-BRII (Moustakas et al., 1993) . IgG fractions were prepared from the mouse ascites or the rabbit serum by ammonium sulfate precipitation followed by DEAE-cellulose chromatography (Harlow and Lane, 1988) . F(ab')2 fragments were generated by pepsin digestion, following the protocols of Kurkela et al. (1988) for mouse IgG or Henis et al. (1985) for rabbit IgG. Fluorophore-labeled affinity-purified antibodies, including fluorescein-coupled goat IgG anti-rabbit IgG (FITCIgG Gc~RIgG) or anti-mouse IgG (G~MIgG), and goat F(ab')2 anti-mouse IgG conjugated to the cyanine dye Cy3.18 (Biological Detection Systems) (Cy3-F[ab']2 Gc~MIgG), were obtained from Jackson Immunoreseareh Labs (West Grove, PA). All the F(ab')2 preparations were reduced by mercaptoethanol and alkylated with iodoacetamide to generate monovaient Fab' fragments (Henis et al., 1985) . To eliminate possible traces of IgG, the Fab' preparations were treated with protein A-Sepharose (for rabbit or goat IgG) or protein G-Sepharose (for mouse IgG). The resulting Fat/were free of contamination by F(ab')2 or IgG, as judged by SDS-PAGE under nonreducing conditions.
Expression Vectors for Epitope-tagged TGF-f3 Receptors
Epitope tagging was performed according to Kolodziej and Young (1991) , using site-directed mutagenesis on uracil-containing single-stranded phageraids (Kunkel et ai., 1987) . The human TGF-~SRII eDNA (H2-3FF clone; Linet ai., 1992) was inserted into the SV-40 expression vector pcDNA-1 (Invitrogen, San Diego, CA) via the EcoRI site on the polylinker (Lin et ai., 1992) . Using this vector, which also carries an MI3 origin of replication, single stranded phagemids were grown in a dut-ung-Escherichia coli strain (CJ236/P3; Invitrogen) with M13K07 (Bio-Rad Laboratories, Cambridge, MA) as helper phage. Site-directed mutagenesis on this template was performed with mutaganic oligonucleotides (Research Genetics, Huntsville, AL) encoding the epitope-tag sequence flanked by the sequences corresponding to nucleotides 62-78 (on the 5' end) and 79-94 (3' end) of the human TGF-13RII (counting the A of the methionine cedon of the eDNA as I; Lin et ai., 1992) . The tag sequences used encoded either the influenza HA epitope YPYDVPDYA (recognized by monoclonai antibody 12CAS; W'dson et ai., 1984) or the human c-myc epitope EQKLISEEDL (recognized by monoclonal antibody 9El0; Evan et ai., 1985) . Each tag was inserted in-frame, nine bases downstream of the putative signal peptide sequence (Lin et al., 1992) . Double stranded pcDNA-I preparations with inserts of the wild-type TGF-~3RII or the epitope-tagged receptors were digested by Pstl, cutting each preparation in three places (at the polylinker, at position 206 in the TGF-~RII eDNA coding sequence, and in the 3' noncoding region of the TGF-/~RII clone). The 3.4-kb piece from the wild-type, untagged reeeptor encoding most of the coding region of the eDNA was ligated with the 4.2-kb piece from a preparation containing HA-or c-myc-tagged NH2-terminal TGF-/3RII sequences and the cloning vector pcDNA-I. The resulting constructs contained as insert all of the TGF-/3RII coding region, most of which was derived from the wild-type, untagged receptor clone, and the NH2-terminal t~,ion (including the tag) derived from the tagged receptor clone. The coding regions derived from the tagged cDNAs (nucleotides 1-206 in the TGF-~RII sequence; Lin et al., 1992) were verified by DNA sequencing.
The rat TGF-/3RIII eDNA (R3-OFF clone; Wang et al., 1991) was inserted into the SV-40 expression vector pcDNA-I/neo 0nvitrogen) via the Hind HI polylinker site. Mutagenesis was carried out as described above for TGF-/3RII, except that the epitope-tag sequences were flanked by sequences corresponding to nueleotides 61-75 (on the 5' end) and 76-90 (3' end) of the rat TGF-/~Rm eDNA sequence (counting the A of the methionine codon of the eDNA as 1, Wang et al., 1991) . This yielded in-frame insertions of the HA or c-myc epitope-tags six bases downstream of the putative signal peptide sequence (Wang et al., 1991) . Double-stranded preparations of peDNA-l/neo with wild-type, untagged rat TGF-/SRIII or with epitope-tagged rat TGF-/SRIII inserts were digested by XbaI, which cut the plasmids at the polylinker, and BstEH, which cut at position 255 of the cDN.gs coding sequence. The 5.5-kb fragment from the wild-type, untagged receptor encoding most of the coding region and 3' untranslated sequences of the eDNA was ligated to the 7.6-kb fragment from a preparation containing HA-or c-myc-tagged NH2-terminal TGF-/~RIII sequences and the cloning vector pcDNA-I/neo. The resulting plasmids contained inserts with all of the TGF-/3RIII coding region, most of which was derived from the wild-type, untagged receptor clone but with nucleotides 1-255 originating from the tagged receptor cDNAs. This region was verified for each tagged receptor by DNA sequencing.
In the case of human TGF-/SRIH, a eDNA clone from HepG2 cells, identical in sequence to the one cloned by Mor6n et al. (1992) , was inserted into pcDNA-I/neo via the HindIII and NotI polylinker sites. Site-directed mutagenesis was performed using oligonueleotides encoding the epitope-tag sequences flanked by the sequences corresponding to nucleotides 672-686 (on the 5' end) and 687-701 (3' end) of the human TGF-/~RIII sequence (counting as 1 the first nucleotide of the published sequence; Mor~n et al., 1992) . The epitope-tags were inserted in-frame at the equivalent position to that in the rat type IH receptor (between Pro 22 and Glu 23 in the human TGF-/3RIII). The entire coding regions of the epitope-tagged TGF-/SRIII cDNAs were sequenced, to verify that they included the tags and did not contain any other mutations.
COS-7 Cell Transfections
COS-7 cells (CRL 1651; American Type Culture Collection, Rockville, MD) were grown in DME supplemented with 10% FCS, 100 U/ml penicillin, and 100 ~tg/ml streptomycin (GIBCO BRL, Gaithersburg, MD). They were transiently transfected by the DEAE-dextran method (Seed and Arutfo, 1987 ) using pcDNA-I or poDNA-I/neo containing the TGF-BRII or m eDNAs (tagged or untagged). Immunofluorescence and ligand binding and/or immunoprecipitation assays were performed 44-48 h after transfection.
Receptor Cross-linking
Binding and cross-linking of 100 pM 125I-'I'GF-~l to cells grown on 6-well trays or 100 nun dishes (Coming Inc., Coming, NY) was as described (Moustakas et al., 1993) . Cross-linked proteins were resolved by 5-10% linear gradient SDS-PAGE under reducing conditions and exposed to Kodak XAR film at -70°C.
Receptor Immunoprecipitation
IgG fractions of 9El0 (a-mye) and 12CA5 (a-HA) monoclonal antibodies were described above. A rabbit pre-immune serum was also used as a nonspecific control for immunopreeipitations. Cell-surface TGF-/~ receptors were labeled with 100 pM 1~I-TG~I as described above. 5 × 106 cells were dissolved in 1 mi of ice-cold immunopreeipitation 0P) buffer (PBS containing 1% Triton-X-100, 1 mM EDTA, and 2 mM phenylmethylsulfonyl fluoride). Extracts were precleared by incubation with 50 t~g/nfl protein A-Sepbarose (Sigma Chemical Co., St. Louis, MO) or protein G-Sepharose (Pharmaeia LKB). Then 5-10 pg/ml of the appropriate IgG was added and reactions were incubated at 40C for 4-12 h. This was followed by addition of 50 gg/ml protein A-Sepbarose (for a-HA and preimmune serum) or 50/tg/ml protein G-Sepharnse (for a-myc) to precipitate the immunocomplexes. The pellets were thoroughly washed in IP buffer. For sequential irnmunoprecipitations of single or double epitope-ta~dged receptors, the immunocomplexes from the first immunoprecipitation reactions were dissolved in a small amount of a solution containing 1% SDS, 50 m_M DTT, and 10% ~-mercaptoethanol, boiled for 5 rain, and mixed thoroughly. The eluted proteins were diluted in IP buffer such that the final SDS concentration was less than 0.1%. Monoclonal IgG's were added at the above-noted concentrations, aad reactions were incubated at 4"C for 12 h. Finally, immunocomplexes were precipitated with protein A-or protein G-Sepbarose as above. These secondary immunopellets were thoroughly washed with IP buffer, dissolved in I.aemmli loading buffer, and subjected to 5-10% linear gradient SDS-PAGE prior to autoradiography.
Immunofluorescence 44-48 h after transfecfion, COS-7 cells were washed twice with serum-free DME, and incubated 30 rain at 37"C to allow digestion of serum-free DME, and incubated 30 rain at 370C to allow digestion of serum-derived ligands. After washing twice with cold I-IBSS (GIBCO BRL) supplemented with 20 mM Hepes and 1% fatty acid-free BSA (Sigma Chemical Co.) (HBSS/ Hepes/BSA, pH 7.2), the cells were incubated in the same buffer (1 h, 4"C) with normal goat IgG (200 t~g/ml) to block nonspeeifie binding. This was followed by successive incubations (45 rain, 4"C, with three washes between incubations) with anti-tag or a-I/N Fab' or IgG (alone or in various combinations), followed by various combinations of goat anti-rabbit Fab' or IgG (unlabeled, or labeled with FITC or with the Cy3 eyanine dye). Cy3, whose excitation and emission wavelengths resemble tetramethyirbodamine, was preferred over tetramethylrhodamine due to its higher fluorescence yield, especially important in Fab' labeling. The details of each successive labeling protocol depend on the specific experiment and are given in the figure legends. The samples were washed three times with cold HBSS/Hepes, fixed successively in methanol (-200C, 5 rain) and acetone (-20"C, 2 rain), and mounted with Slowfade (Molecular Probes, Eugene, OR) mounting solution. Fluorescence micrographs were taken using rhodemine (for Cy3 fluorescence) or FITC (with a narrow band-pass filter) conditions with a 63 x objective, immersed in oil, on a Zeiss Axiophot fluorescence microscope.
Results
To date, only heteromeric complexes of the types I and II, and the types II and m, TGF-fl receptors have been detected. In these studies, radiolabeled TGF-/~ was bound and crosslinked to cell-surface receptors, followed by detergent solubilization, immunoprecipitation with an antireceptor antibody, and gel electrophoresis. While this approach is highly sensitive and can detect low levels of heterocomplexes Inagaki, et al., 1993; L6pez-Casillas et al., 1993; Moustakas et al., 1993) , it is not applicable to the study of homo-oligomers due to the inability to distinguish between identical subunits. Furthermore, detergent solubilization is potentially disruptive for certain noncovalent protein complexes.
To develop a system and method capable of detecting both homo-and hetero-oligomeric complexes containing TGF-/3RII and TGF-BRIII under native conditions, we have tagged each receptor with two different epitopes. The epitope tags were introduced at the NH: termini of the extracellular domains, to enable double-labeling immunofluorescence studies on live cells (Henls et al., 1990) as well as immunoprecipitation studies on affinity-labeled receptors. These types of experiments are performed best at a high receptor density at the cell surface, particularly because this enables good visualization by immunofluorescence. For this reason, transient expression in COS-'/cells was chosen. The human TGF-/3RII eDNA (Lin et al., 1992) in the SV-40 expression vector pcDNA-I was modified such that either a c-myc sequence, recognized by the monoclonal antibody 9El0 (Evan et al., 1985) , or the HA epitope, recognized by the monoclonal antibody 12CA5 (Wilson et al., 1984) , was inserted three amino acids downstream of the putative site of signal peptidase cleavage (the epitope tags are located between Pro 26 and His27). In the case of TGF-/3RIII, both the rat (Wang et al., 1991) and human (Mor6n et al., 1992) cDNAs in the expression vector peDNA-I/neo were modified to include either of the c-myc or HA epitope tags. The tags were inserted two amino acids downstream of the putative site of signal peptidase cleavage in the rat sequence (between Pro 25 and Glu 26) or in the equivalent position in the human TGF-/3RIII sequence (between pro2: and Glu23). When transiently expressed in COS-7 cells using the SV-40 vectors, the tagged receptors were synthesized, delivered to the cell surface, and bound ligand indistinguishably from the wild-type receptors (Fig. 1 A; and data not shown). The insertion of the epitope tag in these specific locations does not interrupt the biological activities of the receptors, as shown for HA-tagged "I'GF-/3RII in a growth-inhibition assay (Wrana et al., 1992) and the c-myc-TGF-f3RIII in an assay based on modulation of the growth-inhibitory response to TGF-/32 (L6pez-Casillas et al., 1993) .
Co-imraunoprecipitation Studies Identify A~inity-labeled TGF-[3RH Homo-Oligomers and TGF-{3RII-TGF-[3RIII Hetero-Oligomers
125I-TGF-/~I was bound and cross-linked to COS-7 cells transfected with various combinations of epitope-tagged or -untagged TGF-BRII (human) and TGF-BRIII (rat or human). Immunoprecipitation on singly transfected cells using a-HA or ot-myc IgG showed that these antibodies precipitate only the type II receptors carrying the appropriate epitope tag ( Fig. 1 A, lanes 6and 10, and B, lane 1), but not untagged receptors or receptors carrying the other tag ( Fig. 1 A, lanes 5, 7, 8 and 9, and B, lane 5) . The same specificity applied to the epitope-tagged type III receptors (Fig. 1 B; and data not shown), the only complication being that the ot-myc IgG cross-reacted weakly with afffinity-labeled HA-tagged type HI receptors (Moustakas, A., data not shown). This limited our analysis of the type III receptors using the affinitylabeling/immunoprecipitation approach and only the appropriate, noncross-reacting combinations of type HI receptors were further tested.
The endogenous TGF-/3 receptors in COS-7 cells were not detectable under the conditions of our binding and crosslinking assay (not shown). Transfection with the eDNA encoding the human TGF-BRII resulted in specific binding and cross-linking of TGF-/3 to this receptor only ( Fig. 1 A, lanes 2-4) and no type I TGF-/3 receptors co-immunoprecipitated with the type II receptors (Fig. I A, lanes 5-10) . Transfeetion with cDNAs encoding the rat (Fig. 1 A, lanes 11-13, and B, lanes 1-4 and 6) or human (not shown) TGF-BRIII resulted in specific binding and cross-linking of TGF-B to the type III receptor as well as to two additional, closely migrating TGF-B-binding proteins of ,~45-52 kD. We have consistently observed these low molecular weight binding proteins in this and other cell systems where the type III receptor is overexpressed (Inagaki et al., 1993) . These affinity-labeled proteins co-precipitate with antibodies specific for the type HI receptor (Moustakas et al., 1993) or with the monoclonal antibodies specific for the appropriate epitope tags used, even under denaturing conditions, suggesting that these species are antigenlcally related to the type III receptor. These proteins are distinct from the TGF-B type I receptor since in this gel system the type I receptor co-migrates exactly with the 69-kD molecular weight marker whereas the doublet migrates faster. Further, neither of the affinity-labeled doublet proteins is precipitated by antibodies specific for the TGF-~RI (Moustakas, A., unpublished results) . Nor do these two proteins exhibit the characteristic sensitivity of the TGF-/3RI to pretreatment of ceils with DTT (Inagaki et al., 1993) and, unlike affinity-labeled type I receptor, they do not coimmunoprecipitate with the type II receptor. These two proteins most probably represent membrane bound forms of the type III receptor whose exact molecular nature remains unknown.
In cells cotransfected with TGF-/3RII and TGF-/~RIII and labeled with I:5I-TGF-~I, immunoprecipitation of one receptor type, carrying a specific epitope tag, was accompanied by detectable co-precipitation of the other receptor type (either untagged or carrying the other tag) (Fig. 1 B, lanes 2, 3, and 6 ). Co-precipitation of affinity-labeled TGF-/3RIII was also detected when TGF-~RII (tagged or untagged) was precipitated using a rabbit polyclonal anti-peptide antibody directed against an NH2-terminal epitope (Lys 3° to Ala .4) of the human TGF-/3RII (a-l/N; Moustakas et al., 1993 ; and data not shown). Co-precipitation of affinity-labeled TGF-/3RI/was detected when TGF-/3RHI (tagged or untagged) was precipitated using a rabbit polyelonal anti-peptide antibody directed against an exoplasmic domain epitope (Gly ~ to Tyr s2°) of the rat TGF-BRHI (Moustakas, A., unpublished results) . These findings are in accord with recent observations on co-immunoprecipitation of TGF-BRII and TGF-BRIII in several cell types (I.xSpez-Casillas et al., 1993; Moustakas et al., 1993) . Addition of any of the above antibodies, at the concentrations used in the immunoprecipitation or immunofluorescence experiments, during the incubation with t25I-TGF-/31 did not affect ligand binding or cross-linking, indicating that these antibodies do not inhibit TGF-B1 binding to either receptor (not shown).
Formation of homo-oligomeric complexes among a single type of TGF-/3 receptor was not studied previously. In order to examine the formation of such complexes, sequential immunoprecipitation experiments were performed on cells coexpressing HA-and c-myc-tagged type II receptors. Fig.  2 shows that these receptors, affinity labeled with Iz*I-TGF-/31, can be co-immunoprecipitated demonstrating that homooligomers of the type 11 receptor exist on the cell surface, at least in the presence of ligand. In the key samples (Fig. 2 B , lanes 7 and 8) cell extracts were immunoprecipitated with one monoclonal anti-epitope antibody, the immunoprecipitates were boiled in a solution containing SDS, and eluted polypeptides were then re-immunoprecipitated with the other monoclonal antibody. The c-myc-tagged type II receptor cross-linked to TGF-BI can be co-immunoprecipitated by the o~-HA monoclonal antibody (Fig. 2 B, lane 7) . It is not co-immunoprecipitated if the cells do not express the HAtagged receptor (Fig. 2 A, lane 5) , nor if a preimmune serum is used for the first immunoprecipitation (B, lane 5). Similarly, HA-tagged type II receptor cross-linked to TGF-B1 can be co-immunoprecipitated with the o~-myc monoclonal antibody ( Fig. 2 B, lane 8) . It is not co-immunoprecipitated if the cells do not express the c-myc-tagged receptor (Fig. 2  A, lane 10) or if the first immunoprecipitation is with a preimmune serum (B, lane 6). Thus, affinity-labeled HAand c-myc-tagged type II receptors are in mutual complexes on the cell surface.
We were unable to demonstrate co-immunoprecipitation of HA-and c-myc-tagged type HI receptors using a similar protocol. Since the immunofluorescence copatching experiments (see below) demonstrate that type HI homo-oligomers do exist, one explanation for this discrepancy is that homooligomeric type HI complexes do not withstand detergent solubilization and thus are not detected by the immunoprecipitation protocol. A second is that, while primary immunoprecipitation of epitope-tagged TGF-BRIII after binding cross-linking was very efficient (Fig. 1 B) , the efficiency of the secondary immunoprecipitation of the denatured type HI receptor (after boiling in SDS) is low.
The immunoprecipitation studies (or any other biochemical assay) cannot quantify the fraction of the receptors that participate in homomeric complexes, since only a subpopulation of the cells coexpress the two cotransfected receptors. lanes 2-7) , HA-tagged type II receptors alone (,4, lanes 8-13), or both epitope-tagged receptors together (B, lane 2-13). Cells were affinity labeled with I00 pM I~I-TGF-~I. The total extracts (T, A, lanes 2, 7, 8, and 13, and B, lanes 2, 9, and 13) were analyzed by 5--10% SDS-PAGE. Cells were solubilized in detergents and subjected to immunoprecipitation with the antibody listed in the numerator: a-myc (M; A, lanes 3, 4, 9, and 10; B, lanes 3, 8, and 10); cx-HA (H; A, lanes 5, 6, 11, and 12; B, 4, 7, and 11) or a control rabbit pre-immtme serum (P; B, lanes 5, 6, and 12). As detailed in Materials and Methods, the immunoprecipitates were dissolved by boiling in SDS, and subjetted to immunopreeipitation using the antibody listed in the denominator: ~x-myc (M; A, lanes 3, 5, 9, and 11; B, 3, 5, and 7); cx-HA (H; A, lanes 4, 6, 10, and 12; B, 4, 6, and 8) ; or the control pre-immune serum (P; B, lanes 10, 11, and 12) . Immunoprecipi Furthermore, the sequential immunoprecipitation experiments examine only a small percentage of the cell-surface receptor population, due to the low efficiency of chemically cross-linking the labeled ligand to the receptors. In addition, heterocomplexes containing both types II and HI TGF-/3 receptors may be preferentially labeled in such studies, since their formation appears to be mediated by the TGF-/3 ligand. Therefore, although they are highly sensitive, the immunoprecipitation studies cannot determine whether the complexes represent a major or a minor fraction of the cell-surface receptors. In spite of these limitations, it is apparent that the fraction of TGF-/3RHI that coprecipitates with HAtagged TGF-/~RII is much smaller than the fraction of c-myctagged TGF-/~RII that coprecipitates with HA-tagged TGF-/3RII (compare Fig. 1 B, lanes I and 2 with Fig. 2 B, lanes  4 and 7) . To further explore these questions, we restored to cell-surface immunofluorescence studies.
Epitope-tagged Receptors Can be Patched on the Surface of Liring Cells
Immunofluorescence copatching experiments, designed to detect 0ligomeric receptors at the surface of live ceils, are based on IgG-mediated patching of one polypeptide chain. The copatching of another chain (carrying a different epitope), labeled exclusively with noncross-linking monovalent Fab' fragments, is then followed. These experiments have several advantages: (a) they examine the bulk of the cell-surface receptors; (b) the use of microscopy enables one to select exclusively the coexpressing cells for analysis; (c) sensitivity of receptor complexes to detergents, as may be the case for type HI receptor homo-oligomers, does not present a problem as there is no detergent-solubilization step; and (d) receptor interactions can be measured in the absence or presence of ligand using the same analytical techniques, unlike biochemical experiments where the method of analysis varies depending on the presence or absence of ligand.
Surface labeling of live COS-7 ceils (performed in the cold, to avoid internalization) expressing tagged or untagged TGF-flRII or TGF-~RIII with fluorescent antibodies is shown in Fig. 3 , which also depicts controls for the labeling specificity. For both TGF-BRII and TGF-BRIII, labeling with noncross-linldng monovalent, Fab' fragments resulted in a diffuse fluorescent pattern (Fig. 3, A and C) . In contrast, labeling with bivalent primary and secondary IgG's led to the formation of conspicuous micropatches, presumably due to IgG-mediated cross-linking (Fig. 3 , B, D, and E). This shift indicates that the receptors are laterally mobile at the cell surface; otherwise they would not be incorporated into patches. This situation is ideal for copatching experiments, since it is relatively, easy to follow the shift of the Fab'-labeled receptors from a homogeneous to a patchy distribution. It should be noted that the ot-IIN rabbit IgG was more effective in inducing patching than or-HA or a-myc, probably due to its polyclonal nature (Fig. 3, compare B and E) . TGF-BRIII underwent IgG-mediated patching less readily than TGF-/~RII (Fig. 3, compare B and D) , for which reason patching of TGF-BRII was preferred whenever possible. Fig. 3 (F-H) are controls for the specificity of the antibodies used.
The Majority of ~ypes H and III Receptors Are Not in Hetero-Oligomers
Experiments showing the lack of copatching of TGF-BRIII with TGF-~RII in the absence of ligand are depicted in Fig.  4 . These experiments employed COS-7 cells cotransfected with TGF-BRII (tagged or untagged) and TGF-/~RIH carrying another epitope-tag. About 40 % of the positive cells expressed both receptor types, and these cells were examined for copatching. As shown in Fig. 4 , the TGF-BRII patches mediated by FITC-IgG (A and E, green) do not overlap with the red fluorescence of the epitope-tagged TGF-BRIII, monitored by Cy3-Fab' (B and F). In the double-exposure photographs (Fig. 4, C, D , and G) the TGF-BRII patches are green, while the Cy3 fluorescence appears as orange, due to the green FITC background. Most of the epitope-tagged TGF-/~RIII is smoothly distributed on the cell surface; only occasional FITC-and Cy3-1abeled patches coincided, giving rise to a yellow color upon double exposure (Fig. 4 , lower part of G). Qualitatively similar results (not shown) were obtained when epitope-tagged TGF-/3RIII was induced into micropatches by appropriate IgG's and epitope-tagged TGF-/~RII was labeled with monovalent Fab'. Importantly, no significant copatching of TGF-BRIII with TGF-/~RII was observed even on double-labeled cells that expressed low levels (just above the limit of detection needed for fluorescence microscopy) of one or both receptors. These results indicate that only a small fraction-below the level that can be unambiguously detected in the ilnmunofluorescence copatching experiments-of the type HI receptors may reside in mutual complexes with TGF-/~RII in live cells and in the absence of ligand. The lack of copatching is not due to incompatibility between human type II and rat type III TGF-/~ receptors, as evidenced by the failure of epitope-tagged human TGF-/~RIII to copatch with human TGF-BRII (Fig. 4 D) .
In view of the findings of co-immunoprecipitation of the types II and III receptors following TGF-/~ binding (see TGF-BRID were labeled with 50 #g/ml FalY derived from the c~-myc monoclonal antibody followed by 20/~g/ml Cy3-tagged FalY goat anti-mouse antibody (Cy3-FalY Gc~MIgG). Cell surface tagged type 1I receptors are uniformly distributed. (B) Cells transfected as in A were labeled with 20 #g/ml intact IgG ~x-myc followed by 20 #g/ml FITC-tagged intact goat anti-mouse IgG (FITC-IgG Gc~MIgG). Cell-surface tagged type H receptors are aggregated into small patches. (C) Cells transfected with the rat type HI receptor carrying the HA epitope at the NHz-terminus (HA-TGF-/3RIID were labeled with 50 ftg/ml FalY derived from the cx-HA monoclonal antibody followed by 20/xg/ml Cy3-FalY Gc~MIgG. Cell-surface tagged type HI receptors are uniformly distributed on the cell surface. (D) Cells transfected as in C were labeled with 20 #g/ml intact c~-HA IgG followed by 20/xg/ml FITC-IgG Gc~MIgG. Many of the cell-surface tagged type HI receptors are aggregated into small patches. (E) Cells were transfected with the wild-type (untagged) TGF-BRII, and labeled with 150 #g/ml of intact IgG purified from a rabbit antipeptide antibody raised against an NH2-terminal peptide of the type II receptor (a-Ha IgG) followed by 30 #g/ml of FITC-labeled goat anti-rabbit IgG (FITC-IgG Gc~RIgG). The cell surface type II receptors are aggregated into small patches. (F) Cells transfected with the wild-type (untagged) rat type HI receptor were labeled with 150 #g]ml of intact c~-HN IgG followed by 30 #g/ml FITC-GczRIgG. No surface labeling is evident on any cells. (G) Cells transfected with c-myc-TGF-fJRII were labeled with 20 #g/ml intact c~-HA IgG followed by 20 #g/ml FITC-IgG Gc~MIgG. No surface labeling is evident on any cells. Similarly, no surface labeling was obtained using cells transfected with untagged TGF-BRII or TGF-BRIII. (H) Cells transfected with rat HA-TGF-/~RIII were labeled with 20 #g/ml intact c~-myc IgG, followed by 20 #g/ml FITC-IgG Gc~MIgG. No surface labeling is evident on any cells. Similarly, no surface labeling was obtained using cells transfected with untagged TGF-BRII or TGF-BRIII. 1; and L6pez-CasiUas et al., 1993), we examined the effects of TGF-/31 and TGF-B2 on copatching of the types II and HI receptors. The results (Fig. 5) clearly show that even in the presence of these ligands, IgG-mediated patching of human TGF-flRII (A and E) does not lead to appreciable copatching of epitope-tagged rat or human TGF-flRIII (B and F). The nonoverlap of the fluorescence is evident in the double exposures in Fig. 5 , C and G. The lighter shade of green in Fig. 5 A is due to a longer exposure time than in E and not due to leakage of Cy3 fluorescence; such leakage is negligible as evidenced by the control experiment in H and I of Fig. 4 . Even addition of disuccinimidyl suberate (DSS) after ligand binding, to cross-link some ligand to its receptor, prior to the IgG-mediated patching did not result in distinctive copatching (Fig. 5, D and H) . The same resuits-absence of copatching of the types III and II receptors-were obtained at several concentrations of TGF-/31 or TGF-fl2 (50 pM, 200 pM, 1 nM; data not shown), excluding the possibility that sub-or over-saturation of the receptors by the ligand interfered with its ability to induce heterocomplexes. Analogous observations-absence of copatching of the types IN and II receptors-were made when epitopetagged TGF-~RIII was induced to patch instead of TGF-/3RII (not shown). It should be noted that the antibodies used in these studies did not affect binding of TGF-~ to its receptors, as evidenced by the absence of effects of these antibodies on affinity labeling by 1~SI-TGF-fll of the types II or III receptors expressed in transfected COS cells (not shown). Similarly, the presence of concentrations of TGF-/31 or TGF-/32 up to 1 nM (the highest tested) had no effect on labeling by the fluorescent antibodies (Fig. 5) . Thus, even in the presence of ligand, the level of type II/type III TGF-fl receptor heterocomplexes must be low. We conclude that only a minor fraction of the cell-surface TGF-flRII and TGF-BRIII are localized in heteromeric complexes.
TGF-[3RH and TGF-[3RIII Exist As Homo-Oligomers on the Plasma Membrane
The experiment in Fig. 6 shows that HA-and c-myc-tagged type II TGF-~ receptors copatch together on the cell surface in the absence (A-C) or presence (D-F) of TGF-~ or TGFfl2. COS-7 cells were cotransfected with c-myc-and HAtagged TGF-flRII. The receptors carrying one epitope tag were forced into patches using primary IgG and FITC-IgG secondary antibodies (Fig. 6, A and D) while the receptors carrying the other tag were labeled with monovalent Fab' and secondary Cy3-Fab' (B and E). As is apparent in the double exposures (Fig. 6, C and F) , a very high percentage of the cell-surface receptors copatch. There are many coincident green and red patches that become yellow upon double exposure (e.g., Fig. 6, long arrows) . Copatching was observed in the absence of ligand (Fig. 6, A-C patches of receptor carrying the other tag (e.g., Fig. 6 , short arrows). Such a phenomenon is expected in the case of small homo-oligomers (dimers or trimers), where the probability is high that some homo-oligomers will consist entirely of receptor polypeptides bearing the same epitope tag and that Similar studies demonstrated copatching of HA-and c-myc-tagged type Ill TGF-15 receptors on the cell surface in the absence (Fig. 7, A-C) or presence (D-F) of TGF-/31. In this case, virtually all of the green patches of tagged type HI TGF-/3 receptors induced by the or-HA IgG's (Fig. 7 , A and D) contained red fluorescence due to the copatched receptors bearing the opposite epitope tag (B and E), as can be seen in the double exposures, where all of the patches are yellow (C and F). However, the inefficient patching of the type HI receptors reduces the resolution in these experiments. Similar results (not shown) were obtained using other TGF-/51 concentrations (50 pM or 1 nM), replacing TGF-/31 by TGF-/32, or cross-linking the ligand to the surface receptors with DSS prior to labeling with antibodies. As in the former cases, no significant differences could be noticed between cells with high versus low surface expression of the receptors.
Discussion
TGF-/~ has a broad range of activities, controlling cell growth, differentiation, and extracellular matrix composition (Massagu~, 1990; Roberts and Sporn, 1990; Moses et al., 1990; Lin and Lodish, 1993) . These responses are elicited and modulated via high-affinity cell-surface receptors, principally the types I, II, and HI receptors. Formation of hom&-or hetero-oligomeric receptor complexes may play an important role in regulating the multiple intracellular signals generated by TGF-/3. Several studies have demonstrated functional and physical interactions among the different receptor subtypes Inagaki et al., 1993; L6pez-Casillas et al., 1993; Moustakas et al., 1993) , but the molecular composition of putative receptor heterooligomers on the cell surface under native conditions is still unknown. Furthermore, the existence of receptor homooligomers has not been explored. Here we investigated homo-and hetero-oligomer formation among types II and HI TGF-/~ receptors using cells co-expressing various combinations of epitope-tagged types II and Ill receptors. We used both antibody-mediated cross-linking and immunofluorescence microscopy on live cells, as well as sequential immunoprecipitation reactions on affinity-labeled cell-surface receptors. These studies demonstrated that both TGF-/3RII and TGF-/3RIII form homo-oligomers at the cell surface, and that type H/type HI receptor heterocomplexes comprise only a minor fraction of the population of cell-surface receptors, implying that the heterocomplexes may represent transient species.
The immunofluorescence copatching experiments on cells coexpressing HA-TGF-/3RII and c-myc-TGF-f3RII, or HA-TGF-{3RIII and c-myc-TGF-13RIII (Figs. 6 and 7) , corroborated by the results of the sequential immunoprecipitation experiments on affinity-labeled TGF-flRII (Fig. 2) , clearly demonstrate for the first time that both types II and 111 TGF-fl receptors form homo-oligomers. These homo-oligomers are detected in the intact cell plasma membrane, and exist prior to ligand binding. Although our experiments used ceils overexpressing the transfected receptors, a situation that might increase nonspecific interactions, there are several indications that the homo-oligomers are not generated as a result of high receptor expression. First, many cell types normally express high physiological levels of the type HI TGF-/3 receptor-~200,000 per cell (Massagu~, 1990)-approximately that found on transfected COS cells that express moderate levels of the type III receptor. Second, even for the type II receptor, which is normally expressed at levels of several thousands per cell, the microscopic nature of the immunofluorescence copatching experiments enabled examination of transfected COS ceils expressing as low as 20,000 type II receptors per cell. (The amount of TGF-flRII at the surface of specific transfected COS-7 cells was evaluated by measuring the fluorescence intensity on single cells labeled by the ol-IIN antibody and a secondary fluorescent IgG, using a photomultiplier tube attached to the microscope. The intensity was compared to that obtained using similarly la- of c-myc-and HA-tagged type II receptors-were the same as in COS cells expressing "~10 times more type II receptor. Third, studies on co-immunoprecipitation of affinity-labeled types II and type 111 receptors expressed in transfected COS-7 ceils gave results similar to those obtained using cells expressing normal amounts of the two receptors (L6pez-Casillas et al., 1993; Moustakas et al., 1993) . Furthermore, the fact that no significant amounts of type IFtype 111 heterocomplexes were detected by immunofluorescence copatching experiments under identical conditions (Figs. 4 and 5) implies that the copatching is specific, and that the experimental conditions used do not lead to the generation of nonspecific aggregates of the TGF-B receptors. Our failure to detect homooligomers of affinity-labeled type l]I receptors by sequential immunoprecipitation, presumably due to the disruption of such complexes by the detergent used to solubilize the cell membranes, also attests to the specificity of formation of the observed complexes of the type 1I receptor on the surface of COS-7 cells and argues against the notion of induction of receptor complex formation by the molecular probes used here. Furthermore, the same experiments demonstrate that the oligomers formed are not simply mediated by the presence of the epitope tags or by the anti-tag antibodies, since otherwise they would also mediate the formation of type H/type I~ complexes, which were not observed in the immunofluorescence studies.
The homo-oligomeric state of TGF-/3RIII is in accord with the report that the related glycoprotein endoglin (L6pez-Casillas et al., 1991; "Wang et al., 1991 ) is a disulfide-linked homodimer (Gougos and Letarte, 1990; Cheifetz et al., 1992) . In the case of the type II receptor, formation of homooligomers is in agreement with reports that overexpression of a truncated kinase-deficient form of the receptor had dominant negative effects on TGF-/3 signaling (Brand et al., 1993; Chen et al., 1993; Wieser et al., 1993) . These studies prompted the suggestion that the impairment in TGF-/3 signaling may be mediated by trans inhibition of autophosphorylation, implying that the receptor can form homo-oligomers. Thus, homo-oligomerization of the type II receptor may enable receptor trans autophosphorylation. Analogous findings were reported for a corresponding kinase-negative type II activin receptor (Hemmati-Brivanlou and Melton, 1992) .
In view of the evidence for functional interactions between TGF-/3RII and TGF-/3RI Inagaki et al., 1993) , it could be argued that type I receptors may stabilize the type H receptor oligomers. However, the low level of TGF-/3RI in the COS-7 cells, relative to the overexpressed type II and/or type 1II receptors (Fig. 1 A) rules out this possibility, and indicates that formation of neither type II nor type HI receptor homo-oligomers require TGF-/3RI. Similarly, the type II/type HI receptor heterocomplexes cannot contain stoichiometric amounts of TGF-/3RI, in accord with recent reports (L6pez-Casillas et al., 1993; Moustakas et al., 1993) . It could also be argued that some other native cellular protein is associated with the observed receptor complexes and is essential for their formation (such a possibility pertains to any type of co-immunoprecipitation or copatching experiment, and therefore also applies to all previous work on TGF-B receptor complexes). In any case, such a candidate protein(s) would have to be expressed normally at high levels, and would have to remain associated with the types II and HI receptors in the detergent solutions used for immunoprecipitation. Such a candidate protein could not be part of the extracellular matrix or cytoskeleton, since membrane proteins that stably interact with these structures are laterally immobile (Edidin, 1987; Jacobson et al., 1987) , while the IgG-mediated shift of TGF-/3RII and TGF-/3RIII from a homogeneous to a patchy distribution demonstrates that the majority of these receptors are laterally mobile.
In the immunofluorescence copatching expe "rtments demonstrating TGF-/3RII homo-oligomerization, a large fraction of HA-TGF-/3RII copatched with c-myc-TGF-~RII, but a significant amount of receptors that did not copatch was also evident (Fig. 6) . This is suggestive of small oligomers, probably dimers or trimers. The reasoning is as follows: (a) If the receptor polypeptides were monomers, no copatching would be seen. (b) If the receptor polypeptides form dimers, and then 50% of the receptors would contain polypeptides with different epitope tags. Only such dimers will undergo copatching. (c) The fraction of oligomers capable of co-patching will increase with the number of subunits in the oligumer (75 % for trimers, 87.5 % for tetramers), since the only receptors that will not copatch are those in which all of the receptor subunits bear the same epitope tag. Although the copatching experiments are semi-quantitative, the fraction of green FITC-IgG patches that does not coincide with red Cy3-Fab' patches is estimated to be between 1/4 and 1/2 (e.g., Fig. 6 ), clearly above the very low level expected for a tetramer or a higher-order oligomer. Thus, if the cell-surface TGF-/3RII population is homogeneous, these receptors most likely form dimers or tfimers. However, the type II receptor population might be heterogeneous with a subpopulation that does not form homo-oligomers and thus does not copatch. In this case, it is possible that higher order receptor oligomers comprise the fraction that shows copatching. In the immunofluorescence copatching experiment demonstrating the oligomerit structure of the type rrl receptors (Fig. 7) , it was not possible to discern non-coincident patches; however, the resolution in this particular experiment is lower in view of the inherent low efficiency of the anti-epitope monoclonal antibodies in inducing patching of the type III receptors. It is therefore difficult to draw conclusions concerning the possible size of the TGF-/3RIII homo-oligomers.
The immunoprecipitation experiments on cells coexpressing types II and ITI TGF-/3 receptors demonstrated coprecipitation of the two receptor types affinity-labeled by TGF-3 ligand (Fig. 1 B) . These findings are in agreement with similar recent studies (L6pez-Casillas et al., 1993; Moustakas et al., 1993) which detected ligand-induced TGF-/SRII/TGF-/3RII/heterocomplexes. The present study further explores these heterocomplexes by examining the bulk population of the receptors at the cell surface-and not only those crosslinked to the ligand-using immunofluorescence copatching experiments (Fig. 4 and 5) . These studies revealed for the first time that the vast majority of the types 1I and HI receptors do not reside in mutual complexes, even in the presence of ligand. Indeed, a 1:1 stoichiometry is unlikely in view of the fact that in most cells TGF-/3RIII is much more abundant than TGF-/3RII (Wang et al., 1991; L6pez-Casillas et al., 1991) . The percentage of the types II and 11I receptors residing in heterocomplexes is low-probably below 10%-since it cannot be detected in the copatching experiments. In any case, it must be well below the percentage of type II and type III receptors present as homo-oligomers, where copatching L6pez-Casillas et al. (1993) , except that the individual receptors may already be part of a homo-oligomer. That is, what were assumed in earlier work to be complexes of TGF-/3 with one type II and one type [] (or one type II and one type I) receptor could actually be complexes of one TGF-/~ with one homodimer of a type II and one homodimer of a type [] receptor. Direct association of TGF-flRI with preformed TGF-/3RII homo-oligomers is also possible. Further experiments on the oligomeric structure of TGF-/3RI and on its interactions with TGF-~RII and TGF-flRIII are required to address these issues. The existence of TGF-fl receptor complexes of different compositions offers the potential for a wide repertoire of responses to the same family of ligands, depending on the equilibrium between the different receptor complexes. These in turn may regulate the multiple intracellular signals generated by TGF-/3.
